Skip to main content

Loading market data...

QGEN

Qiagen N.V.

NYSE • United states

$50.00

+$1.10

(+2.25%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Qiagen N.V. (QGEN)

Unavailable

Quotes may be delayed

$10.30B

Market Cap

11,965,671

Volume

Unavailable

P/E Ratio

0.70%

Div Yield

Qiagen N.V. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: HULSTERWEG 82, PL VENLO, P7
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

5 Jun 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Qiagen N.V..

10 Feb 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Qiagen N.V..

6 Feb 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Qiagen N.V..

8 Jan 2026

Qiagen N.V. filed Form 25-NSE

Qiagen N.V. submitted Form 25-NSE to the SEC.

12 Nov 2025

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Qiagen N.V..

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$839.01M

Total assets (USD)$6.28B

Shareholders' equity (USD)$3.78B

Long-term debt (USD)$1.65B

Debt due within a year (USD)$0

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 31 Dec 2025

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Verified Financial Statements Unavailable

Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Buy

Target: $47.21

-5.6% upside potential

📈

Strong Buy

Unavailable

👍

Buy

5

⏸️

Hold

5

📉

Sell

0

10 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 06:50 UTC Targets range 40.00–55.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

15

Jun 2007

QIAGEN NV

10% owner

Open-market purchase

$1.35 per share

10,000 shares

12

Jun 2007

QIAGEN NV

10% owner

Open-market purchase

$1.29 per share

10,000 shares

4

Jun 2007

QIAGEN NV

10% owner

Open-market purchase

$1.31 per share

50,000 shares

31

May 2007

QIAGEN NV

10% owner

Open-market purchase

$1.31 per share

5,000 shares

30

May 2007

QIAGEN NV

10% owner

Open-market purchase

$1.31 per share

30,000 shares

29

May 2007

QIAGEN NV

10% owner

Open-market purchase

$1.31 per share

10,000 shares

23

May 2007

QIAGEN NV

10% owner

Open-market purchase

$1.29 per share

17,500 shares

9

May 2007

QIAGEN NV

10% owner

Option exercise

$0.45 per share

240,000 shares

Top Shareholders

Wellington Management Group Llp

12,406,763 shares

-13.628% change

6/30/2026

Price T Rowe Associates Inc /Md/

11,354,379 shares

34.701% change

6/30/2026

Vanguard Group Inc

9,065,797 shares

1.253% change

12/31/2025

Principal Financial Group Inc

6,648,681 shares

120281.695% change

6/30/2026

Vanguard Capital Management Llc

6,209,904 shares

1.697% change

6/30/2026

Blackrock, Inc.

5,905,678 shares

12.479% change

6/30/2026

Morgan Stanley

5,042,391 shares

20.317% change

6/30/2026

Earnest Partners Llc

4,573,455 shares

18.223% change

6/30/2026

Goldman Sachs Group Inc

4,443,674 shares

219.384% change

6/30/2026

Norges Bank

4,325,135 shares

24.641% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 06:50 UTC· 24 minutes ago

Research coverage and investment tools

Qiagen N.V. (QGEN) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its last price was US$50.00 on 21 Oct 2026. That is 69% of the way from its 52-week low of US$32.53 to its 52-week high of US$57.82. It paid US$0.35 a share in dividends over the last 12 months, a dividend yield of 0.70%. The latest ex-dividend date on file is 7 Jul 2026. Its market capitalisation was US$10.3 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/5/2026	$0.62	$0.60	+3.3%
Mar 2026	5/6/2026	$0.54	$0.54	0.0%
Dec 2025	2/4/2026	$0.62	$0.61	+1.6%
Sep 2025	11/4/2025	$0.64	$0.61	+4.9%

Cash and equivalents: $839.01M
Total assets: $6.28B
Shareholders' equity: $3.78B
Long-term debt: $1.65B
Debt due within a year: $0

SCHEDULE 13G/A · 5 Jun 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Qiagen N.V..
SCHEDULE 13G/A · 10 Feb 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Qiagen N.V..
SCHEDULE 13G · 6 Feb 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Qiagen N.V..
25-NSE · 8 Jan 2026 · Delisting Completed

Qiagen N.V. filed Form 25-NSE (opens in a new tab)

Qiagen N.V. submitted Form 25-NSE to the SEC.
SCHEDULE 13G/A · 12 Nov 2025

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Qiagen N.V..

Insider	Date	Transaction	Shares	Average price	Filing
QIAGEN NV 10% owner	15 Jun 2007	Open-market purchase (P)	+10,000	$1.35	Form 4 (opens in a new tab)
QIAGEN NV 10% owner	12 Jun 2007	Open-market purchase (P)	+10,000	$1.29	Form 4 (opens in a new tab)
QIAGEN NV 10% owner	4 Jun 2007	Open-market purchase (P)	+50,000	$1.31	Form 4 (opens in a new tab)
QIAGEN NV 10% owner	31 May 2007	Open-market purchase (P)	+5,000	$1.31	Form 4 (opens in a new tab)
QIAGEN NV 10% owner	30 May 2007	Open-market purchase (P)	+30,000	$1.31	Form 4 (opens in a new tab)
QIAGEN NV 10% owner	29 May 2007	Open-market purchase (P)	+10,000	$1.31	Form 4 (opens in a new tab)
QIAGEN NV 10% owner	23 May 2007	Open-market purchase (P)	+17,500	$1.29	Form 4 (opens in a new tab)
QIAGEN NV 10% owner	9 May 2007	Option exercise (X)	+240,000	$0.45	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Wellington Management Group Llp	6/30/2026	12,406,763	-13.628%
Price T Rowe Associates Inc /Md/	6/30/2026	11,354,379	34.701%
Vanguard Group Inc	12/31/2025	9,065,797	1.253%
Principal Financial Group Inc	6/30/2026	6,648,681	120281.695%
Vanguard Capital Management Llc	6/30/2026	6,209,904	1.697%
Blackrock, Inc.	6/30/2026	5,905,678	12.479%
Morgan Stanley	6/30/2026	5,042,391	20.317%
Earnest Partners Llc	6/30/2026	4,573,455	18.223%
Goldman Sachs Group Inc	6/30/2026	4,443,674	219.384%
Norges Bank	6/30/2026	4,325,135	24.641%

Previous close: 48.90 USD
Day range: 46.89 – 50.25 USD
52-week range: 32.53 – 57.82 USD
Volume: 11,965,671
Market cap: $10.30B
Average volume: 1,351,534
EPS (FY 2025, diluted): 1.94 USD
Dividends (last 12 months): 0.35 USD
Dividend yield: 0.70%
Ex-dividend date: 7 Jul 2026
Shares outstanding: 206.07M
Beta (5Y monthly): 0.59

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 11 hours ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:19 UTC· 56 minutes ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:19 UTC· 56 minutes ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for QGEN yet

Financial statements
Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.